Today: 9 June 2026
Imperial Brands share price lifts as buyback filing lands after ex-dividend drop
20 February 2026
1 min read

Imperial Brands share price lifts as buyback filing lands after ex-dividend drop

London, Feb 20, 2026, 08:38 GMT — Regular session underway.

  • Imperial Brands shares ticked up roughly 0.6% early, recovering some ground after Thursday’s ex-dividend slide.
  • The company reported a fresh round of share buybacks set for cancellation, part of its £1.45 billion repurchase program.
  • Next up for investors: the trading update on April 14, right after the dividend record date.

Imperial Brands (IMB.L) edged up roughly 0.6% to 3,220 pence early Friday in London, just outpacing the wider UK market.

Awkward timing, though not unusual. The stock went ex-dividend on Thursday; buyers from that point miss out on the upcoming payout. That shift alone usually knocks the price down, even if everything else stays put.

Imperial’s shares trade not just on growth hopes but for income, so the calendar counts. The company is set to pay out a final dividend of 40.08 pence per share on March 31, with Feb. 20 as the record date.

Imperial reported late Thursday it snapped up 474,606 shares for an average 3,210.90 pence apiece, picking up stock anywhere from 3,188 to 3,248 pence. These shares are set to be cancelled, trimming the count of shares in issue (not counting treasury shares) to 790,606,141, according to the filing.

The buyback comes out of the £1.45 billion programme the company rolled out in October—a key tool management relies on to return cash to shareholders.

Thursday, the numbers took over—shares dropped 1.6%, settling at 3,200 pence as the stock went ex-dividend.

Buybacks help soften dips at the edges by providing consistent demand. Still, they leave a bigger question hanging for long-term investors: can pricing power continue to make up for shrinking volumes as cigarette markets reach maturity?

The company is set to deliver a trading update April 14, then will release half-year results May 12.

Imperial’s approach on cash returns lands it alongside bigger names like British American Tobacco and Philip Morris. For these firms, dividends and buybacks carry much of the equity narrative.

The downside? Still hanging over the sector. A stricter regulatory stance on nicotine, particularly for vaping, or a sudden move in excise taxes can squeeze both volumes and margins fast. When that happens, investors usually mark down the entire group at once.

Stock Market Today

  • CorVel CEO Michael Combs Rings Nasdaq Opening Bell
    June 9, 2026, 9:49 AM EDT. CorVel (Nasdaq: CRVL), a provider of risk management solutions, marked its presence at the Nasdaq MarketSite in Times Square. Michael Combs, President and CEO, honored the event by ringing the Opening Bell, a ceremonial start to the trading day signaling attention to the company's market activities.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe
Previous Story

Uber stock: Tuesday test looms after Uber Eats targets $1 billion boost in Europe

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next
Next Story

Tesco share price nudges toward 52-week high after UK retail sales jump — what to watch next

Go toTop